@article{f5f9e606df4745689d473805ae81cc6d,
title = "Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease",
abstract = "Advanced chronic kidney disease (CKD) is associated with poor outcomes in patients who underwent surgical aortic valve replacement, whereas its prognostic role in transcatheter aortic valve implantation (TAVI) remains unclear. This study aimed to investigate outcomes in patients with advanced CKD who underwent TAVI. A total of 1,904 consecutive patients who underwent balloon-expandable TAVI in 33 centers between 2007 and 2012 were enrolled in the Italian Transcatheter Balloon-Expandable Valve Implantation Registry. Advanced CKD was defined according to the estimated glomerular filtration rate: 15 to 29 ml/min/1.73 m2 stage 4 (S4), <15 ml/min/1.73 m2 stage 5 (S5). Edwards Sapien or Sapien-XT prosthesis were used. The primary end point was all-cause mortality during follow-up. Secondary end points were major adverse cardiac events at 30 days and at follow-up, defined with Valve Academic Research Consortium 2 criteria. A total of 421 patients were staged S5 (n = 74) or S4 (n = 347). S5 patients were younger and had more frequently porcelain aorta and a lower incidence of previous stroke. Periprocedural and 30-day outcomes were similar in S5 and S4 patients. During 670 (±466) days of follow-up, S5 patients had higher mortality rates (69% vs 39%, p <0.01) and cardiac death (19% vs 9%, p = 0.02) compared with S4 patients. Male gender (hazard ratio [HR] 1.6, 95% confidence interval [CI] 1.2 to 2.2), left ventricular ejection fraction <30% (HR 2.3, 95% CI 1.3 to 4), atrial fibrillation (HR 1.4, 95% CI 1.0 to 1.9), and S5 CKD (HR 1.5, 95% CI 1.0 to 2.1) were independent predictors of death. In conclusion, TAVI in predialytic or dialytic patients (i.e., S5) is independently associated with poor outcomes with more than double risk of death compared with patients with S4 renal function. Conversely, in severe CKD (i.e., S4) a rigorous risk stratification is required to avoid the risk of futility risk. {\textcopyright} 2017 Elsevier Inc.",
keywords = "insulin, acute heart infarction, aged, aorta, aorta dissection, aortic valve repair, aortic valve replacement, Article, atrial fibrillation, cerebrovascular accident, chronic kidney failure, device failure, diabetes mellitus, endocarditis, estimated glomerular filtration rate, EuroSCORE, female, follow up, forward heart failure, heart death, heart disease, heart left ventricle ejection fraction, hemodialysis, human, Kaplan Meier method, kidney function, major clinical study, male, mortality, new-onset atrial fibrillation, pacemaker implantation, percutaneous aortic valve, priority journal, prosthetic valve dysfunction, transcatheter aortic valve implantation, very elderly, Aortic Valve Stenosis, complication, glomerulus filtration rate, heart stroke volume, Kidney Failure, Chronic, Postoperative Complications, proportional hazards model, register, severity of illness index, sex difference, treatment outcome, Aged, Aged, 80 and over, Atrial Fibrillation, Female, Glomerular Filtration Rate, Humans, Male, Mortality, Proportional Hazards Models, Registries, Renal Dialysis, Renal Insufficiency, Chronic, Severity of Illness Index, Sex Factors, Stroke Volume, Transcatheter Aortic Valve Replacement, Treatment Outcome",
author = "F. Conrotto and S. Salizzoni and A. Andreis and F. D'Ascenzo and A. D'Onofrio and M. Agrifoglio and A. Chieffo and A. Colombo and F. Rapetto and F. Santini and G. Tarantini and D. Gabbieri and C. Savini and S. Imm{\`e} and F. Ribichini and O. Valsecchi and M. Aiello and G. Lixi and A. Iadanza and E. Pompei and M. Stolcova and D. Ornaghi and A. Minati and M. Cassese and G.L. Martinelli and P. Sbarra and A. Agostinelli and A. Audo and A. Pieroni and R. Fiorilli and G. Gerosa and M. Rinaldi and F. Gaita",
note = "Cited By :2 Export Date: 2 March 2018 CODEN: AJCDA Correspondence Address: Conrotto, F.; Division of Cardiology, A.O.U. Citt{\`a} della Salute e della Scienza di TorinoItaly; email: federico.conrotto@gmail.com Chemicals/CAS: insulin, 9004-10-8 Tradenames: Edwards Sapien; Sapien XT References: Ronco, C., McCullough, P., Anker, S.D., Anand, I., Aspromonte, N., Bagshaw, S.M., Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative (2010) Eur Heart J, 31, pp. 703-711; Kahn, M.R., Robbins, M.J., Kim, M.C., Fuster, V., Management of cardiovascular disease in patients with kidney disease (2013) Nat Rev Cardiol, 10, pp. 261-273; Thourani, V.H., Keeling, W.B., Sarin, E.L., Guyton, R.A., Kilgo, P.D., Dara, A.B., Impact of preoperative renal dysfunction on long-term survival for patients undergoing aortic valve replacement (2011) Ann Thorac Surg, 91, pp. 1798-1807; Leon, M.B., Smith, C.R., Mack, M., Miller, D.C., Moses, J.W., Svensson, L.G., Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery (2010) N Engl J Med, 363, pp. 1597-1607; Smith, C.R., Leon, M.B., Mack, M.J., Miller, D.C., Moses, J.W., Svensson, L.G., Transcatheter versus surgical aortic-valve replacement in high-risk patients (2011) N Engl J Med, 364, pp. 2187-2198; D'Ascenzo, F., Moretti, C., Salizzoni, S., Bollati, M., D'Amico, M., Ballocca, F., 30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study (2013) Int J Cardiol, 167, pp. 1514-1518; Ferro, C.J., Chue, C.D., de Belder, M.A., Moat, N., Wendler, O., Trivedi, U., Impact of renal function on survival after transcatheter aortic valve implantation (TAVI): an analysis of the UK TAVI registry (2015) Heart, 101, pp. 546-552; Allende, R., Webb, J.G., Munoz-Garcia, A.J., de Jaegere, P., Tamburino, C., Dager, A.E., Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients (2014) Eur Heart J, 35, pp. 2685-2696; Salizzoni, S., D'Onofrio, A., Agrifoglio, M., Colombo, A., Chieffo, A., Cioni, M., Besola, L., Rinaldi, M., TAVI Team, Early and mid-term outcomes of 1904 patients undergoing transcatheter balloon-expandable valve implantation in Italy: results from the Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) (2016) Eur J Cardiothorac Surg, 50, pp. 1139-1148; Levey, A.S., Eckardt, K.-U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) (2005) Kidney Int, 67, pp. 2089-2100; Kappetein, A.P., Head, S.J., G{\'e}n{\'e}reux, P., Piazza, N., van Mieghem, N.M., Blackstone, E.H., Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2) (2012) Eur J Cardiothorac Surg, 42, pp. S45-S60; The official website of the euroSCORE cardiac surgery scoring system http://www.euroscore.org/, [Internet]. [cited 2016 Dec 30]. Available at: Accessed on January 9, 2017; Zoghbi, W.A., Enriquez-Sarano, M., Foster, E., Grayburn, P.A., Kraft, C.D., Levine, R.A., Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography (2003) J Am Soc Echocardiogr, 16, pp. 777-802; D'Ascenzo, F., Cavallero, E., Biondi-Zoccai, G., Moretti, C., Omed{\`e}, P., Bollati, M., Castagno, D., Sheiban, I., Use and misuse of multivariable approaches in interventional cardiology studies on drug-eluting stents: a systematic review (2012) J Interv Cardiol, 25, pp. 611-621; Chen, C., Zhao, Z.-G., Liao, Y.-B., Peng, Y., Meng, Q.-T., Chai, H., Impact of renal Dysfunction on mid-term outcome after transcatheter aortic valve implantation: a systematic review and Meta-analysis (2015) PLoS One, 10, p. e0119817; Lindman, B.R., Alexander, K.P., O'Gara, P.T., Afilalo, J., Futility, benefit, and transcatheter aortic valve replacement (2014) JACC Cardiovasc Interv, 7, pp. 707-716; Smilde, T.D.J., Damman, K., van der Harst, P., Navis, G., Westenbrink, B.D., Voors, A.A., Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failure (2008) Clin Res Cardiol, 98, pp. 121-129; Conrotto, F., D'Ascenzo, F., Salizzoni, S., Presbitero, P., Agostoni, P., Tamburino, C., Tarantini, G., Marra, S., A gender based analysis of predictors of all cause death after transcatheter aortic valve implantation (2014) Am J Cardiol, 114, pp. 1269-1274; D'Ascenzo, F., Ballocca, F., Moretti, C., Barbanti, M., Gasparetto, V., Mennuni, M., D'Amico, M., Gaita, F., Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacement (2013) J Cardiovasc Med (hagerstown), 14, pp. 894-898; Schaefer, U., Zahn, R., Abdel-Wahab, M., Gerckens, U., Linke, A., Schneider, S., Comparison of outcomes of patients with Left Ventricular Ejection Fractions ≤30% versus ≥30% having transcatheter aortic valve implantation (from the German transcatheter aortic valve interventions registry) (2015) Am J Cardiol, 115, pp. 656-663; Chopard, R., Teiger, E., Meneveau, N., Chocron, S., Gilard, M., Laskar, M., Baseline characteristics and prognostic Implications of pre-existing and new-onset atrial fibrillation after transcatheter aortic valve implantation: Results from the FRANCE-2 registry (2015) JACC Cardiovasc Interv, 8, pp. 1346-1355; Maeda, K., Kuratani, T., Torikai, K., Ichibori, Y., Nakatani, K., Onishi, T., Early outcomes in Japanese dialysis patients treated with transcatheter aortic valve implantation (2015) Circ J, 79, pp. 2713-2719",
year = "2017",
doi = "10.1016/j.amjcard.2017.01.042",
language = "English",
volume = "119",
pages = "1438--1442",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "9",
}